Dayagdag, Esterlita R.

HRN: 16-37-49  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/03/2023
CEFTAZIDIME 1GM (VIAL)
11/03/2023
11/10/2023
IV
1gm
TID
CAP On Top Of PTB
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: